NYSE:TDOC - Teladoc Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$49.85 +0.25 (+0.50 %)
(As of 05/23/2018 04:00 PM ET)
Previous Close$49.30
Today's Range$49.25 - $50.20
52-Week Range$27.30 - $50.60
Volume24,159 shs
Average Volume1.17 million shs
Market Capitalization$3.11 billion
P/E Ratio-30.26
Dividend YieldN/A
Beta0.35

About Teladoc (NYSE:TDOC)

Teladoc logoTeladoc, Inc. provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone. It serves employers of Fortune 1000 companies, health plans, health systems, and other entities. Teladoc, Inc. was founded in 2002 and is headquartered in Purchase, New York.

Receive TDOC News and Ratings via Email

Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Offices & clinics of medical doctors
Sub-IndustryN/A
SectorMedical
SymbolNYSE:TDOC
CUSIPN/A
Phone203-635-2002

Debt

Debt-to-Equity Ratio0.38
Current Ratio4.15
Quick Ratio4.15

Price-To-Earnings

Trailing P/E Ratio-30.26
Forward P/E Ratio-36.39
P/E GrowthN/A

Sales & Book Value

Annual Sales$233.28 million
Price / Sales13.32
Cash FlowN/A
Price / CashN/A
Book Value$8.84 per share
Price / Book5.64

Profitability

EPS (Most Recent Fiscal Year)($1.65)
Net Income$-106,780,000.00
Net Margins-41.06%
Return on Equity-20.40%
Return on Assets-12.48%

Miscellaneous

Employees1,231
Outstanding Shares62,330,000

Teladoc (NYSE:TDOC) Frequently Asked Questions

What is Teladoc's stock symbol?

Teladoc trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

How were Teladoc's earnings last quarter?

Teladoc (NYSE:TDOC) issued its earnings results on Tuesday, May, 1st. The health services provider reported ($0.39) EPS for the quarter, beating analysts' consensus estimates of ($0.43) by $0.04. The health services provider earned $89.64 million during the quarter, compared to analyst estimates of $86.77 million. Teladoc had a negative return on equity of 20.40% and a negative net margin of 41.06%. Teladoc's revenue was up 109.0% on a year-over-year basis. During the same period in the prior year, the company posted ($0.30) earnings per share. View Teladoc's Earnings History.

What guidance has Teladoc issued on next quarter's earnings?

Teladoc updated its FY18 earnings guidance on Tuesday, May, 1st. The company provided earnings per share (EPS) guidance of ($1.41-1.36) for the period, compared to the Thomson Reuters consensus earnings per share estimate of ($1.35). The company issued revenue guidance of $350-360 million, compared to the consensus revenue estimate of $356.28 million.Teladoc also updated its Q2 guidance to ($0.37-0.35) EPS.

What price target have analysts set for TDOC?

16 analysts have issued twelve-month price objectives for Teladoc's shares. Their predictions range from $35.00 to $50.00. On average, they anticipate Teladoc's stock price to reach $43.00 in the next twelve months. View Analyst Ratings for Teladoc.

What are Wall Street analysts saying about Teladoc stock?

Here are some recent quotes from research analysts about Teladoc stock:
  • 1. Cantor Fitzgerald analysts commented, "4Q17 in line or slightly better than expected. Revenue was $77 million vs. our estimate and FactSet of consensus of $76 million. Visits grew 49%. PMPM was $0.95 vs. $0.91 in 3Q17. Gross margin declined y/y given the expected revenue shift. TDOC reported positive adjusted EBITDA of $2.4M vs FactSet $2.5M. GAAP EPS included several non-recurring/non-cash items. Overall, we believe that TDOC had a strong quarter." (2/27/2018)
  • 2. According to Zacks Investment Research, "The stock of Teladoc has outperformed the industry year to date. The company is witnessing steady business growth with insurers and customers increasingly embracing telehealth. It’s organic growth initiative remains on track. With a number of acquisitions completed since its inception, the company has expanded its distribution capabilities and broadened its service offering. Also the company boasts an impressive clientele. The company has also provided strong guidance for 2017. The company has incurred significant losses in each period since its inception in 2002. Teladoc has been unable to generate cash from operations and we have doubts over its ability to do so in the coming quarters. Its high debt level has caused a spike in interest expense which has dented its operating margins." (10/18/2017)

Who are some of Teladoc's key competitors?

Who are Teladoc's key executives?

Teladoc's management team includes the folowing people:
  • Mr. Jason Gorevic, CEO & Director (Age 46)
  • Mr. Peter A. McClennen, Pres (Age 49)
  • Mr. Mark J. Hirschhorn, Chief Financial Officer, Chief Operating Officer and Exec. VP (Age 53)
  • Mr. Adam C. Vandervoort, Chief Legal Officer and Sec. (Age 43)
  • Mr. Michael King, Chief Sales Officer (Age 55)

When did Teladoc IPO?

(TDOC) raised $112 million in an initial public offering (IPO) on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

Has Teladoc been receiving favorable news coverage?

Headlines about TDOC stock have trended positive on Wednesday, according to Accern Sentiment. The research group identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Teladoc earned a news impact score of 0.40 on Accern's scale. They also assigned news headlines about the health services provider an impact score of 47.09 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Who are Teladoc's major shareholders?

Teladoc's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.83%), JPMorgan Chase & Co. (7.51%), Eagle Asset Management Inc. (3.90%), Bamco Inc. NY (3.11%), Zevenbergen Capital Investments LLC (2.52%) and Global Thematic Partners LLC (2.05%). Company insiders that own Teladoc stock include Adam C Vandervoort, Andrew Turitz, James K Outland, Jason N Gorevic, Lp Chp III, Mark Hirschhorn, Michael Goldstein, Michael H King, Peter A Mcclennen and Trident Capital Fund Vi Lp. View Institutional Ownership Trends for Teladoc.

Which institutional investors are selling Teladoc stock?

TDOC stock was sold by a variety of institutional investors in the last quarter, including Columbus Circle Investors, Hood River Capital Management LLC, BlackRock Inc., Prudential Financial Inc., Tiverton Asset Management LLC, Loomis Sayles & Co. L P, Great West Life Assurance Co. Can and RMB Capital Management LLC. Company insiders that have sold Teladoc company stock in the last year include Adam C Vandervoort, Andrew Turitz, Jason N Gorevic, Mark Hirschhorn, Michael Goldstein and Peter A Mcclennen. View Insider Buying and Selling for Teladoc.

Which institutional investors are buying Teladoc stock?

TDOC stock was bought by a variety of institutional investors in the last quarter, including Global Thematic Partners LLC, Bellevue Group AG, Millennium Management LLC, Baillie Gifford & Co., Redmile Group LLC, Wells Fargo & Company MN, D L Carlson Investment Group Inc. and IFP Advisors Inc. View Insider Buying and Selling for Teladoc.

How do I buy shares of Teladoc?

Shares of TDOC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Teladoc's stock price today?

One share of TDOC stock can currently be purchased for approximately $49.85.

How big of a company is Teladoc?

Teladoc has a market capitalization of $3.11 billion and generates $233.28 million in revenue each year. The health services provider earns $-106,780,000.00 in net income (profit) each year or ($1.65) on an earnings per share basis. Teladoc employs 1,231 workers across the globe.

How can I contact Teladoc?

Teladoc's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The health services provider can be reached via phone at 203-635-2002 or via email at [email protected]


MarketBeat Community Rating for Teladoc (TDOC)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  336 (Vote Outperform)
Underperform Votes:  172 (Vote Underperform)
Total Votes:  508
MarketBeat's community ratings are surveys of what our community members think about Teladoc and other stocks. Vote "Outperform" if you believe TDOC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TDOC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Teladoc (NYSE:TDOC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
16 Wall Street analysts have issued ratings and price targets for Teladoc in the last 12 months. Their average twelve-month price target is $43.00, suggesting that the stock has a possible downside of 13.74%. The high price target for TDOC is $50.00 and the low price target for TDOC is $35.00. There are currently 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.752.802.75
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $43.00$41.9286$39.5385$39.0909
Price Target Upside: 13.74% downside1.89% upside4.32% upside24.10% upside

Teladoc (NYSE:TDOC) Consensus Price Target History

Price Target History for Teladoc (NYSE:TDOC)

Teladoc (NYSE:TDOC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/2/2018SunTrust BanksBoost Price TargetBuy ➝ Positive$48.00HighView Rating Details
5/2/2018Craig HallumSet Price TargetHold$32.00 ➝ $39.00HighView Rating Details
4/13/2018Canaccord GenuityReiterated RatingBuy$45.00LowView Rating Details
4/6/2018Wells Fargo & CoSet Price TargetBuy$46.00HighView Rating Details
3/15/2018KeyCorpReiterated RatingOverweight ➝ Overweight$41.00 ➝ $50.00LowView Rating Details
3/15/2018Deutsche BankDowngradeBuy ➝ Hold$45.00LowView Rating Details
2/28/2018Chardan CapitalReiterated RatingBuy ➝ Buy$48.00 ➝ $47.00HighView Rating Details
2/27/2018Cantor FitzgeraldReiterated RatingNeutral ➝ Hold$31.00 ➝ $35.00HighView Rating Details
1/26/2018Jefferies GroupInitiated CoverageBuy$40.00HighView Rating Details
1/4/2018CitigroupInitiated CoverageBuyMediumView Rating Details
11/21/2017CIBCReiterated RatingOutperform ➝ Outperform$40.00 ➝ $45.00N/AView Rating Details
11/21/2017OppenheimerBoost Price TargetOutperform$40.00 ➝ $45.00N/AView Rating Details
9/30/2017CowenReiterated RatingOutperform$39.00MediumView Rating Details
9/29/2017Piper Jaffray CompaniesReiterated RatingBuy$42.00LowView Rating Details
9/18/2017Robert W. BairdDowngradeOutperform ➝ Neutral$14.00 ➝ $36.00HighView Rating Details
6/20/2017William BlairReiterated RatingOutperformHighView Rating Details
8/28/2016FBR & CoReiterated RatingBuyN/AView Rating Details
6/1/2016Stifel NicolausInitiated CoverageHoldN/AView Rating Details
(Data available from 5/23/2016 forward)

Earnings

Teladoc (NYSE:TDOC) Earnings History and Estimates Chart

Earnings by Quarter for Teladoc (NYSE:TDOC)

Teladoc (NYSE:TDOC) Earnings Estimates

2018 EPS Consensus Estimate: ($1.41)
2019 EPS Consensus Estimate: ($0.88)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20185($0.48)($0.38)($0.43)
Q2 20186($0.37)($0.34)($0.36)
Q3 20186($0.33)($0.30)($0.32)
Q4 20186($0.33)($0.28)($0.31)
Q1 20193($0.31)($0.23)($0.27)
Q2 20193($0.23)($0.22)($0.22)
Q3 20193($0.21)($0.19)($0.20)
Q4 20193($0.22)($0.15)($0.19)

Teladoc (NYSE TDOC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/1/2018Q1 2018($0.43)($0.39)$86.77 million$89.64 millionViewListenView Earnings Details
2/27/2018Q4 2017($0.40)($0.50)$76.14 million$77.14 millionViewN/AView Earnings Details
11/1/2017Q3($0.30)($0.55)$67.53 million$68.70 millionViewN/AView Earnings Details
8/2/2017Q2 2017($0.26)($0.28)$44.39 million$44.60 millionViewListenView Earnings Details
5/8/2017Q1 2017($0.33)($0.30)$42.22 million$42.90 millionViewListenView Earnings Details
3/1/2017Q416($0.35)($0.31)$36.73 million$37.40 millionViewListenView Earnings Details
10/27/2016Q316($0.36)($0.33)$32.29 million$32.40 millionViewListenView Earnings Details
8/3/2016Q216($0.39)($0.38)$28.20 million$26.50 millionViewN/AView Earnings Details
5/10/2016Q116($0.38)($0.40)$26.64 million$26.90 millionViewListenView Earnings Details
3/2/2016Q415($0.41)($0.39)$21.89 million$22.60 millionViewN/AView Earnings Details
11/2/2015Q315($0.35)($0.35)$19.31 million$19.97 millionViewN/AView Earnings Details
8/12/2015Q215($0.43)($0.46)$17.06 million$18.30 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Teladoc (NYSE:TDOC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Teladoc (NYSE TDOC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.95%
Insider Trading History for Teladoc (NYSE:TDOC)
Institutional Ownership by Quarter for Teladoc (NYSE:TDOC)

Teladoc (NYSE TDOC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/15/2018Jason N GorevicCEOSell25,000$48.93$1,223,250.00636,184View SEC Filing  
5/2/2018Mark HirschhornVPSell69,460$43.73$3,037,485.8050,042View SEC Filing  
4/16/2018Jason N GorevicCEOSell25,000$41.36$1,034,000.00661,184View SEC Filing  
3/12/2018Jason N GorevicCEOSell40,000$43.27$1,730,800.00View SEC Filing  
3/7/2018Peter A. McclennenPresidentSell27,533$43.01$1,184,194.33View SEC Filing  
3/6/2018Andrew TuritzSVPSell36,210$40.39$1,462,521.9016,700View SEC Filing  
3/5/2018Adam C VandervoortInsiderSell47,123$39.36$1,854,761.2819,338View SEC Filing  
3/2/2018Adam C VandervoortInsiderSell27,809$38.62$1,073,983.5819,338View SEC Filing  
3/2/2018Andrew TuritzSVPSell19,245$39.25$755,366.2516,700View SEC Filing  
3/2/2018Michael GoldsteinDirectorSell66,574$39.72$2,644,319.2854,325View SEC Filing  
2/28/2018Mark HirschhornCFOSell100,000$39.60$3,960,000.0098,960View SEC Filing  
12/4/2017Jason N GorevicCEOSell100,000$32.99$3,299,000.00718,261View SEC Filing  
12/4/2017Mark HirschhornCFOSell30,000$32.99$989,700.005,203View SEC Filing  
11/2/2017Jason N GorevicCEOSell20,000$32.10$642,000.00838,261View SEC Filing  
10/17/2017Mark HirschhornVPSell35,000$32.84$1,149,400.0020,887View SEC Filing  
10/16/2017Mark HirschhornCFOSell25,000$32.37$809,250.0020,887View SEC Filing  
10/2/2017Jason N GorevicCEOSell20,000$33.47$669,400.00View SEC Filing  
10/2/2017Mark HirschhornVPSell10,000$34.04$340,400.00View SEC Filing  
9/22/2017Mark HirschhornVPSell25,000$31.93$798,250.0064,987View SEC Filing  
8/7/2017Adam C VandervoortInsiderSell53,806$30.92$1,663,681.5233,008View SEC Filing  
6/6/2017Jason N GorevicCEOSell19,991$32.89$657,503.99831,650View SEC Filing  
6/5/2017Jason N GorevicCEOSell13,389$32.89$440,364.21831,650View SEC Filing  
5/25/2017Jason N GorevicCEOSell5,600$29.57$165,592.00823,861View SEC Filing  
5/23/2017Jason N GorevicCEOSell14,400$29.57$425,808.00822,961View SEC Filing  
5/17/2017Mark HirschhornVPSell100,000$27.70$2,770,000.0080,887View SEC Filing  
5/8/2017Jason N GorevicCEOSell15,000$23.11$346,650.00833,261View SEC Filing  
4/19/2017Mark HirschhornVPSell59,100$25.46$1,504,686.00180,887View SEC Filing  
4/19/2017Michael H KingInsiderSell5,000$25.75$128,750.0061,459View SEC Filing  
1/26/2017Mark HirschhornVPSell900$20.00$18,000.00239,987View SEC Filing  
1/24/2017Jason N GorevicCEOSell100,000$15.79$1,579,000.00926,158View SEC Filing  
1/24/2017Trident Capital Fund Vi LpMajor ShareholderSell250,000$15.79$3,947,500.00View SEC Filing  
1/19/2017Michael H KingInsiderSell5,000$19.00$95,000.0066,459View SEC Filing  
1/17/2017Mark HirschhornVPSell10,000$17.84$178,400.00240,887View SEC Filing  
1/9/2017Mark HirschhornVPSell5,000$17.50$87,500.00250,887View SEC Filing  
12/15/2016Mark HirschhornVPSell5,000$16.60$83,000.00255,887View SEC Filing  
12/14/2016Lp Chp IIIMajor ShareholderSell500,000$16.36$8,180,000.00View SEC Filing  
11/16/2016Mark HirschhornVPSell10,000$17.19$171,900.00258,387View SEC Filing  
11/10/2016Mark HirschhornVPSell5,000$17.50$87,500.00267,687View SEC Filing  
10/17/2016Mark HirschhornVPSell5,000$15.52$77,600.00268,387View SEC Filing  
8/16/2016Jason N GorevicCEOSell40,000$17.92$716,800.00967,258View SEC Filing  
8/11/2016Michael H KingInsiderSell25,000$17.20$430,000.0091,459View SEC Filing  
8/8/2016Adam C VandervoortInsiderSell52,865$16.64$879,673.6046,685View SEC Filing  
8/2/2016James K OutlandDirectorSell10,000$18.00$180,000.0049,089View SEC Filing  
7/15/2016Jason N GorevicCEOSell5,000$15.45$77,250.00932,258View SEC Filing  
6/29/2016James K OutlandDirectorSell10,000$15.00$150,000.0059,089View SEC Filing  
6/29/2016Jason N GorevicCEOSell5,000$15.01$75,050.00932,258View SEC Filing  
3/17/2016Dana G Jr. MeadDirectorBuy10,000$10.65$106,500.0090View SEC Filing  
9/10/2015William H FristDirectorBuy4,500$22.54$101,430.004,500View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Teladoc (NYSE TDOC) News Headlines

Source:
DateHeadline
Teladoc (TDOC) CEO Sells $1,223,250.00 in StockTeladoc (TDOC) CEO Sells $1,223,250.00 in Stock
www.americanbankingnews.com - May 17 at 7:36 PM
$86.67 Million in Sales Expected for Teladoc (TDOC) This Quarter$86.67 Million in Sales Expected for Teladoc (TDOC) This Quarter
www.americanbankingnews.com - May 16 at 3:46 AM
-$0.35 EPS Expected for Teladoc (TDOC) This Quarter-$0.35 EPS Expected for Teladoc (TDOC) This Quarter
www.americanbankingnews.com - May 14 at 9:29 AM
Teladoc (TDOC) Receives Consensus Recommendation of "Buy" from BrokeragesTeladoc (TDOC) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - May 14 at 8:28 AM
Heres Why Teladoc Reaches a 52 Week High, Stock Up 22%Here's Why Teladoc Reaches a 52 Week High, Stock Up 22%
www.zacks.com - May 11 at 6:23 PM
Here's Why Teladoc Reaches a 52 Week High, Stock Up 22%Here's Why Teladoc Reaches a 52 Week High, Stock Up 22%
finance.yahoo.com - May 11 at 6:23 PM
3 Healthcare Stocks Growing Over 100%3 Healthcare Stocks Growing Over 100%
finance.yahoo.com - May 11 at 8:23 AM
Teladoc's Rising Patient Visits Make for a Good Start to 2018Teladoc's Rising Patient Visits Make for a Good Start to 2018
finance.yahoo.com - May 10 at 5:59 PM
Reviewing Envision Healthcare (EVHC) & Teladoc (TDOC)Reviewing Envision Healthcare (EVHC) & Teladoc (TDOC)
www.americanbankingnews.com - May 10 at 3:33 PM
Teladocs Rising Patient Visits Make for a Good Start to 2018Teladoc's Rising Patient Visits Make for a Good Start to 2018
www.fool.com - May 10 at 12:46 PM
BRIEF-Teladoc Issues $287.5 Mln Aggregate Principal Amount Of 1.375 Pct Convertible Senior Notes Due 2025BRIEF-Teladoc Issues $287.5 Mln Aggregate Principal Amount Of 1.375 Pct Convertible Senior Notes Due 2025
www.reuters.com - May 9 at 8:01 AM
Interesting TDOC Put And Call Options For January 2019Interesting TDOC Put And Call Options For January 2019
www.nasdaq.com - May 8 at 5:59 PM
Q2 2018 EPS Estimates for Teladoc Reduced by Analyst (TDOC)Q2 2018 EPS Estimates for Teladoc Reduced by Analyst (TDOC)
www.americanbankingnews.com - May 7 at 1:24 AM
Teladoc Prices Upsized Offering of $250 Million of Convertible Senior Notes Due 2025Teladoc Prices Upsized Offering of $250 Million of Convertible Senior Notes Due 2025
globenewswire.com - May 4 at 8:04 AM
Teladoc (TDOC) Expected to Earn Q2 2018 Earnings of ($0.35) Per ShareTeladoc (TDOC) Expected to Earn Q2 2018 Earnings of ($0.35) Per Share
www.americanbankingnews.com - May 4 at 7:10 AM
KeyCorp Research Analysts Reduce Earnings Estimates for Teladoc (TDOC)KeyCorp Research Analysts Reduce Earnings Estimates for Teladoc (TDOC)
www.americanbankingnews.com - May 4 at 7:10 AM
Oppenheimer Analysts Lift Earnings Estimates for Teladoc (TDOC)Oppenheimer Analysts Lift Earnings Estimates for Teladoc (TDOC)
www.americanbankingnews.com - May 4 at 7:10 AM
Q2 2018 EPS Estimates for Teladoc Cut by Piper Jaffray (TDOC)Q2 2018 EPS Estimates for Teladoc Cut by Piper Jaffray (TDOC)
www.americanbankingnews.com - May 4 at 7:10 AM
Q2 2018 Earnings Estimate for Teladoc (TDOC) Issued By William BlairQ2 2018 Earnings Estimate for Teladoc (TDOC) Issued By William Blair
www.americanbankingnews.com - May 4 at 7:10 AM
Insider Selling: Teladoc (TDOC) VP Sells 69,460 Shares of StockInsider Selling: Teladoc (TDOC) VP Sells 69,460 Shares of Stock
www.americanbankingnews.com - May 2 at 7:22 PM
BRIEF-Teladoc Announces Proposed Offering Of $225 Million Of Convertible Senior Notes Due 2025BRIEF-Teladoc Announces Proposed Offering Of $225 Million Of Convertible Senior Notes Due 2025
www.reuters.com - May 2 at 5:50 PM
Teladoc Announces Proposed Offering of $225 Million of Convertible Senior Notes due 2025Teladoc Announces Proposed Offering of $225 Million of Convertible Senior Notes due 2025
finance.yahoo.com - May 2 at 5:50 PM
Teladoc (TDOC) Upgraded at ValuEngineTeladoc (TDOC) Upgraded at ValuEngine
www.americanbankingnews.com - May 2 at 4:20 PM
Teladoc (TDOC) Issues  Earnings Results, Beats Estimates By $0.04 EPSTeladoc (TDOC) Issues Earnings Results, Beats Estimates By $0.04 EPS
www.americanbankingnews.com - May 2 at 1:40 PM
Teladoc (TDOC) Given "Hold" Rating at Craig HallumTeladoc (TDOC) Given "Hold" Rating at Craig Hallum
www.americanbankingnews.com - May 2 at 12:52 PM
Teladoc (TDOC) PT Raised to $48.00Teladoc (TDOC) PT Raised to $48.00
www.americanbankingnews.com - May 2 at 12:52 PM
Teladoc (TDOC) Loss Lower Than Expected, 18 View IntactTeladoc (TDOC) Loss Lower Than Expected, '18 View Intact
www.zacks.com - May 2 at 8:06 AM
Teladocs (TDOC) CEO Jason Gorevic on Q1 2018 Results - Earnings Call TranscriptTeladoc's (TDOC) CEO Jason Gorevic on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 2 at 8:06 AM
Edited Transcript of TDOC earnings conference call or presentation 1-May-18 9:00pm GMTEdited Transcript of TDOC earnings conference call or presentation 1-May-18 9:00pm GMT
finance.yahoo.com - May 2 at 8:05 AM
Teladoc (TDOC) Loss Lower Than Expected, '18 View IntactTeladoc (TDOC) Loss Lower Than Expected, '18 View Intact
finance.yahoo.com - May 2 at 8:05 AM
Teladoc (TDOC) Updates FY18 Earnings GuidanceTeladoc (TDOC) Updates FY18 Earnings Guidance
www.americanbankingnews.com - May 1 at 6:32 PM
Teladoc (TDOC) Issues Q2 Earnings GuidanceTeladoc (TDOC) Issues Q2 Earnings Guidance
www.americanbankingnews.com - May 1 at 6:32 PM
BRIEF-Teladoc Q1 Loss Per Share $0.39BRIEF-Teladoc Q1 Loss Per Share $0.39
www.reuters.com - May 1 at 5:29 PM
Teladoc Announces First Quarter 2018 ResultsTeladoc Announces First Quarter 2018 Results
finance.yahoo.com - May 1 at 5:29 PM
Will Teladoc (TDOC) Q1 Earnings Buoy On Severe Flu Season?Will Teladoc (TDOC) Q1 Earnings Buoy On Severe Flu Season?
www.zacks.com - April 30 at 9:09 AM
American Well Moves Into Hospital-Based Telehealth With Avizia DealAmerican Well Moves Into Hospital-Based Telehealth With Avizia Deal
finance.yahoo.com - April 30 at 9:09 AM
Financial Comparison: Teladoc (TDOC) and Concord Medical Services (CCM)Financial Comparison: Teladoc (TDOC) and Concord Medical Services (CCM)
www.americanbankingnews.com - April 28 at 3:22 AM
$86.80 Million in Sales Expected for Teladoc (TDOC) This Quarter$86.80 Million in Sales Expected for Teladoc (TDOC) This Quarter
www.americanbankingnews.com - April 28 at 2:13 AM
Teladoc (TDOC) Expected to Announce Earnings of -$0.43 Per ShareTeladoc (TDOC) Expected to Announce Earnings of -$0.43 Per Share
www.americanbankingnews.com - April 26 at 9:20 PM
Teladoc Announces U.S. Launch of Behavioral Health NavigatorTeladoc Announces U.S. Launch of Behavioral Health Navigator
finance.yahoo.com - April 25 at 5:43 PM
Teladoc (TDOC) Scheduled to Post Quarterly Earnings on TuesdayTeladoc (TDOC) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - April 24 at 11:16 AM
Teladoc (TDOC) and Envision Healthcare (EVHC) Head-To-Head ContrastTeladoc (TDOC) and Envision Healthcare (EVHC) Head-To-Head Contrast
www.americanbankingnews.com - April 22 at 11:24 PM
Chardan Capital Boosts Teladoc (TDOC) Price Target to $41.00Chardan Capital Boosts Teladoc (TDOC) Price Target to $41.00
www.americanbankingnews.com - April 20 at 8:00 PM
Teladoc (TDOC) Receives Consensus Rating of "Buy" from AnalystsTeladoc (TDOC) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - April 19 at 10:45 AM
Analyzing iKang Healthcare Group (KANG) and Teladoc (TDOC)Analyzing iKang Healthcare Group (KANG) and Teladoc (TDOC)
www.americanbankingnews.com - April 19 at 5:39 AM
Teladoc to Announce First Quarter 2018 Financial ResultsTeladoc to Announce First Quarter 2018 Financial Results
finance.yahoo.com - April 18 at 5:55 PM
Jason N. Gorevic Sells 25,000 Shares of Teladoc (TDOC) StockJason N. Gorevic Sells 25,000 Shares of Teladoc (TDOC) Stock
www.americanbankingnews.com - April 18 at 4:10 PM
Teladoc (TDOC) Downgraded to Hold at BidaskClubTeladoc (TDOC) Downgraded to Hold at BidaskClub
www.americanbankingnews.com - April 16 at 12:19 AM
Head-To-Head Analysis: iKang Healthcare Group (KANG) and Teladoc (TDOC)Head-To-Head Analysis: iKang Healthcare Group (KANG) and Teladoc (TDOC)
www.americanbankingnews.com - April 14 at 7:23 PM
Teladocs (TDOC) "Buy" Rating Reaffirmed at Canaccord GenuityTeladoc's (TDOC) "Buy" Rating Reaffirmed at Canaccord Genuity
www.americanbankingnews.com - April 14 at 7:21 AM

SEC Filings

Teladoc (NYSE:TDOC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Teladoc (NYSE:TDOC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Teladoc (NYSE TDOC) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.